Drug Development Drugs Pharma R&D Science 
Drug Discovery World
APRIL 24, 2024
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has supported the use of artificial intelligence (AI) to deliver benefit for patients, life science companies and society, in response to the EU Artificial Intelligence (AI) Act.
DrugBaron
JANUARY 31, 2024
Both the cost and the time required for each new drug approval have increased exponentially for decades (aptly tagged ‘Eroom’s Law’, being the inverse of price drops and speed gains in the semiconductor industry). There is, of course, no evidence of whether the claims made for AI in discovery and development are hype or reality.
Expert insights. Personalized for you.
130 
Let's personalize your content